www.genethique.org

Bioethic information and analysis newsletter

Previous letter Previous Letter

Following Letter

Following Letter

N°96 - December 2007

 

Major scientific advances in research on adult stem cells

Pluripotent adult stem cells
Two research teams – one Japanese, directed by Shinya Yamanaka, from the University of Kyoto, and the other one, American, directed by James Thompson, from the University of Wisconsin-Madison – announced to have succeeded in creating human pluripotent stem cells lines from fibroblasts, cells constituting the epidermis. These works have been published respectively in the scientific magazines Cell and Science in November 2007. Human skin cells have been reprogrammed, by introducing four different genes through a retrovirus, to be transformed into cells, called iPS, having the same properties as embryonic stem cells; in other words capable of differentiation into various types of human body cells. This revolutionary advance is the application to human of the first discovery made by Yamanaka: in August 2006, by inserting four genes in mouse skin cells, he obtained cells with the same potential of embryonic stem cells (v. Gènéthique n°90). This new technique would also have the advantage to eliminate any risk of transplantation rejection, as it should allow creating stem cells with the same patient’s genetic code. Since then, researchers from Whitehead Institute for Biomedical Research, Cambridge (Massachusetts) declare to have cared, with these cells, drepanocytic mice and S. Yamanaka succeeded in eliminating the risk of tumour pulling aside the responsible gene.

Ian Wilmut renounces cloning
These results lead us in a totally new era of biology of stem cells”, expressed Professor Ian Wilmut from Roslin Institute of Edinburgh. The scientific "father" of the cloned sheep Dolly has just announced he will abandon his researches on cloning, for the benefit of production of stem cells without embryo. Then he renounces exploiting the licence he obtained, two years ago, to clone human embryos and wants to join Professor Yamanaka’s researches which seem to be more promising than those on embryos. “Now we can envisage the moment when a simple method will be used to generate any tissue from a very small sample taken from any one of us”.

Reactions of scientists
For Jean-Claude Ameisen, chairman of Inserm ethics committee, “the work of Yamanaka real scientific revolution, proves that it is possible to reprogram ordinary adult cells and shows that plasticity of cells is greater than we thought. With this technique,
we cannot say anymore: there is no other way (than the research on embryo, editor’s note)”. Jean-Claude Ameisen also says: “10 years have passed between the first cloned sheep and the first cloned primates, 15 years have been necessary to pass from mouse embryonic stem cells to human embryonic stem cells and only one year was necessary for S. Yamanaka to pass from his discovery on animal to its application on human”. Regarding Axel Kahn, director of Cochin Institute, he estimates that “in the perspective of the regenerative medicine, it is the most important advance since the birth of Dolly, ten years ago”. In the context of the revision of bioethics laws foreseen in 2009, he adds that “it is not urgent to authorise the creation of embryonic stem cells by nuclear transfer for therapeutic purposes” (in other words the cloning, editor’s note).

Cord blood stem cells
Within another field which is also promising, during the conference on adult stem cells and cord blood cells, organized in the Senate on last 22 December, Dr Nico Forraz (University of Newcastle) announced the future launching of an international consortium about research on cord blood stem cells, called Novus Sanguis. Created by Pr Colin McGuckin’s team (University of Newcastle) and the Jérôme Lejeune Foundation, Novus Sanguis will gather laboratories from various countries.

Embryonic research: impasse
As Pierre-Olivier Arduin, in charge of the commission on Bioethics of the diocese of Fréjus-Toulon shows it, regarding these advances; it seems that France “persists in scientific absurdity” supporting embryonic research. No scientific publication mentions a treatment based on embryonic stem cells, particularly because they have an important chromosomal instability and are carcinogenic, whereas big industrial groups like L’Oréal or LVMH invest in research on adult stem cells. This “enormous discrepancy … is heavily questioning the authorisation decisions of research protocols by the Agency of biomedicine. The decriminalisation of research on embryo is, according to the law, subject to two conditions: one of "being susceptible to allow major therapeutic advances" and the other one "of not being followed by an alternative method of comparable efficacy"… When’s a claim from ill patient associations against the State for non-application of the law of 4 August 2004?(1)


1. Décryptage, 22 novembre 2007

 

Genetically incorrect – Living happy with a genetic anomaly – N. Journet 1

Génétiquement incorrect (Genetically incorrect) follows the interview granted by Didier Sicard, chairman of the National Consultative Ethics Committee, on last 5 February, to the french daily newspaper Le Monde. He denounced the generalisation of prenatal screening (DPN) and the selection of embryos: “I am deeply worried about the systematic character of screenings; about a system of unique thinking… the screening reduces the person to a characteristic. This is the way some people wants that Marfan’s disease is systematically screened particularly suffered by President Lincoln and Mendelssohn. Today, Mozart, because he probably suffered from Gilles de la Tourette disease, Einstein and his left hypertrophied brain… the central truth is that the essential of the prenatal screening activity is aiming at deletion and not at treatment. So, this screening opens up a terrifying prospect: the one of eradication. And this is maybe more real in France than in other countries”. Some days after, Nicolas Journet obtained a market place of ideas in the same daily newspaper, in which he opposed, as the "first concerned", the development of DPN and its application
to "his" disease. From there his book was born.

Prenatal diagnosis and eugenics
Nicolas Journet suffers from Marfan’s syndrome and this orphan disease has a permanent threatening of cardiac arrest. From the adolescence, he discovered the lack of treatment of genetic diseases, and above all the cold and accusing look from physicians who consider it as a problem to eliminate and make his parents feel guilty: for medical professionals, he should not have been born. Nevertheless, genetic disease and happiness are not incompatible! Through this speech as distressing as beneficial, he really wants to prove that he has the right to exist, to be happy and even to have children.

A reform of Telethon
In the name of the right to the difference, N. Journet asks a reform of Telethon he accuses to” favour the development of a eugenic policy in France, by granting funds to researches on embryo selection and prenatal diagnosis”. He asks the allocation of Telethon funds is controlled by the State, to prevent this serious drift of public health in France. “In 1935, Carel talked about gas chamber! In 2007, to eliminate the defective ones, we have the prenatal diagnosis, much more urban. And we have something better, the preimplantation diagnosis”.

"The human and the Animal
Why to write Human with a capital letter if it will be selected as an animal after centuries of scientific advances? Nicolas Journet is surprised to see how animals are sometimes more cherished than we Humans are: “I am in the same situation as the white Bengal tiger, another natural mutant. It suffers from a recessive disease, the leucism, which gives its coat this particular colour. But it is welcome in zoological parks all around the world. The animals have the right to be different. Their particularity justifies a personal security… from one hand, the genetic defect of an animal is a vital element of the biological diversity of our planet. At the same time, any genetic anomaly in human is to be harshly fought”.


1. Génétiquement incorrect, Nicolas Journet, ed. Danger Public, nov. 2007.


 

Interrupted pregnancies: the taboo of psychological consequences

Two recent books deal with the taboo of interrupted pregnancies and the psychological consequences on woman and her circle.

How old would he be today? (1)
Doctor Stéphane Clerget, psychiatrist, has just written “Quel âge aurait-il aujourd’hui? Le tabou des grossesses interrompues” (How old would he be today? The taboo of interrupted pregnancies) in order to prevent, accompany and care psychological consequences of spontaneous abortions, voluntary pregnancy terminations, and medically pregnancy termination. It is what thought a psychiatrist, a priori not opposed to abortion, who, through confidences collected during his consultations, describes the mental marks left by a pregnancy termination in woman, but also in her family, and particularly in her present and future children. From traumatism to depression, from hanger to denial or to culpability, he explains the various reactions, sometimes denied by the circle and proposes remedies among which the social reconnaissance of perinatal mourning, expanded to spontaneous abortions. Dr Clerget recommends to legitimate the moral pain of losing an embryo or foetus, whatever the cause, and to implement secular or religious mourning rituals. To relief these pains, we have to recognize them.

Prohibited pains
Since the Veil law of 1975, 4 to 5 million women in France resorted to abortion. Many of them come and visit a psychiatrist, for a resistant depression, for fears of death and are surprised to discover that this started some times after a VTP. But for ideological reasons no one in France does not dare to talk about psychological and physiological consequences of abortion.

Accompanying these pains
Le traumatisme post-avortement” (The post-abortion trauma) by Dr F. Allard and J.R Fropo (2), through various testimonies and the analysis of Anglo-Saxon medical literature lifts the curtain on these pains and urges women to talk about it and accept to be accompanied to overcome a trial which affects the familial serenity.


1. Quel âge aurait-il aujourd’hui ? Le tabou des grossesses interrompues – Stéphane Clerget - ed. Fayard - oct. 2007

2. Le traumatisme post-avortement - F. Allard, J.R Fropo, ed. Salvator - août 2007

 

  is a monthly newsletter, distributed free of charge, and published by the Jérôme Lejeune Foundation. Director of the Publication : Jean-Marie Le Méné - Editor in chief : Aude Dugast
37 rue des Volontaires - 75725 Paris Cedex 15 - France - Tel : +33 (0)1.44.49.73.39 - ISSN 1638-198 X
contact@genethique.org

 

Subscribe today to weekly Press Review or monthly Newsletter, it's free!

 

Traduction by A.R-TRADUCTION